Kiniksa Pharmaceuticals, Ltd.KNSANASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+36.3%
5Y CAGR+105.1%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
+36.3%/yr
Annual compound
5Y CAGR
+105.1%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
36.3x
Strong expansion
Streak
2 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 269.28% |
| 2024 | -81.04% |
| 2023 | -357.81% |
| 2022 | 106.24% |
| 2021 | 0.46% |
| 2020 | 7.41% |
| 2019 | -57.14% |
| 2018 | -65.38% |
| 2017 | -172.48% |
| 2016 | 0.00% |